PE20010579A1 - Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos - Google Patents

Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos

Info

Publication number
PE20010579A1
PE20010579A1 PE2000000894A PE0008942000A PE20010579A1 PE 20010579 A1 PE20010579 A1 PE 20010579A1 PE 2000000894 A PE2000000894 A PE 2000000894A PE 0008942000 A PE0008942000 A PE 0008942000A PE 20010579 A1 PE20010579 A1 PE 20010579A1
Authority
PE
Peru
Prior art keywords
mesoprogestines
modulars
components
progesterone receptor
female contraceptives
Prior art date
Application number
PE2000000894A
Other languages
English (en)
Spanish (es)
Inventor
Walter Elger
Kristof Chwalisz
Gerd Schubert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PE20010579A1 publication Critical patent/PE20010579A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE2000000894A 1999-08-31 2000-08-31 Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos PE20010579A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38613399A 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
PE20010579A1 true PE20010579A1 (es) 2001-06-04

Family

ID=23524305

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000894A PE20010579A1 (es) 1999-08-31 2000-08-31 Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos

Country Status (28)

Country Link
EP (1) EP1605949A2 (bg)
JP (1) JP2003511399A (bg)
KR (1) KR20020038745A (bg)
CN (1) CN1384748A (bg)
AR (1) AR025455A1 (bg)
AU (1) AU781835B2 (bg)
BG (1) BG106441A (bg)
BR (1) BR0013711A (bg)
CA (1) CA2383650A1 (bg)
CO (1) CO5190694A1 (bg)
CZ (1) CZ2002707A3 (bg)
EA (1) EA006805B1 (bg)
EE (1) EE200200103A (bg)
HR (1) HRP20020265A2 (bg)
HU (1) HUP0202515A3 (bg)
IL (1) IL148415A0 (bg)
LT (1) LT5001B (bg)
LV (1) LV12940B (bg)
MX (1) MXPA02002186A (bg)
NO (1) NO20020998L (bg)
NZ (1) NZ517470A (bg)
PE (1) PE20010579A1 (bg)
PL (1) PL353994A1 (bg)
SI (1) SI20853A (bg)
SK (1) SK2982002A3 (bg)
UA (1) UA77150C2 (bg)
WO (1) WO2001026603A2 (bg)
YU (1) YU13902A (bg)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
AU2003255355A1 (en) * 2002-08-02 2004-02-25 Schering Aktiengesellschaft Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
US20050215535A1 (en) * 2004-03-24 2005-09-29 Kristof Chwalisz Sequential SPRM/progestin treatment
EP1773344A1 (en) * 2004-07-07 2007-04-18 Wyeth a Corporation of the State of Delaware Cyclic progestin regimens and kits
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
ES2602134T3 (es) 2009-04-14 2017-02-17 Laboratoire Hra Pharma Procedimiento para anticoncepción bajo demanda
CN110548034A (zh) * 2019-07-12 2019-12-10 广州莎蔓生物科技有限公司 一种怀孕阻断药物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054271A (en) 1932-05-17 1936-09-15 Schering Kahlbaum Ag Production of crystallized hormone esters
DE699310C (de) 1936-11-20 1940-11-27 Chemische Ind Ges Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols
US2225419A (en) 1937-03-01 1940-12-17 Schering Corp Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols
US2611773A (en) 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US2990414A (en) 1957-03-26 1961-06-27 Syntex Sa 17-undecenoate of estradiol
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
DK174071B1 (da) * 1987-09-24 2002-05-21 Jencap Res Ltd Kontraceptivt præparat i form af en pakning omfattende enhedsdoser
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
US5516769A (en) 1993-02-19 1996-05-14 The Medical College Of Hampton Roads Method of inhibiting fertilization
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4429398C2 (de) 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption
DE4429397C2 (de) 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
NZ295365A (en) * 1994-10-24 1999-07-29 Schering Ag Competitive progesterone antagonists for regulating female fertility as required
US6040340A (en) * 1996-05-07 2000-03-21 Schering Aktiengesellschaft Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors
CA2255863A1 (en) * 1996-06-25 1997-12-31 Akzo Nobel Nv Progestogen-anti-progestogen regimens
WO1998005679A2 (en) * 1996-08-05 1998-02-12 Duke University Mixed agonists of the progesterone receptor and assays therefor
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
CA2371273A1 (en) * 1999-05-04 2000-11-09 Andrew Fensome Tetracyclic progesterone receptor modulator compounds and methods

Also Published As

Publication number Publication date
BR0013711A (pt) 2002-05-07
BG106441A (bg) 2002-09-30
CN1384748A (zh) 2002-12-11
YU13902A (sh) 2006-01-16
NZ517470A (en) 2004-03-26
AR025455A1 (es) 2002-11-27
HUP0202515A3 (en) 2004-06-28
WO2001026603A2 (en) 2001-04-19
AU781835B2 (en) 2005-06-16
CZ2002707A3 (cs) 2002-11-13
HRP20020265A2 (en) 2004-02-29
HUP0202515A2 (hu) 2002-12-28
NO20020998D0 (no) 2002-02-28
UA77150C2 (en) 2006-11-15
KR20020038745A (ko) 2002-05-23
NO20020998L (no) 2002-03-14
CA2383650A1 (en) 2001-04-19
EP1605949A2 (en) 2005-12-21
JP2003511399A (ja) 2003-03-25
LT2002035A (lt) 2002-10-25
MXPA02002186A (es) 2002-09-02
EA006805B1 (ru) 2006-04-28
SK2982002A3 (en) 2002-07-02
EA200200284A1 (ru) 2002-10-31
PL353994A1 (en) 2003-12-15
SI20853A (sl) 2002-10-31
LT5001B (lt) 2003-03-25
AU3215001A (en) 2001-04-23
EE200200103A (et) 2003-04-15
LV12940B (en) 2003-06-20
CO5190694A1 (es) 2002-08-29
WO2001026603A3 (en) 2002-01-17
IL148415A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
KR970706001A (ko) 습식-과립화를 통해 투여단위를 제조하는 방법 (process of making dosage units by wet granulation)
BRPI0512991A (pt) uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto
AR011480A1 (es) ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA.
RS50972B (sr) Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate
TW200605880A (en) Progesterone receptor antagonist contraceptive regimens and kits
AU560487B2 (en) Contraceptive comprising gestodene and ethinylestradiol
ECSP055629A (es) COMPOSICIÓN QUE CONTIENE UN ESTEROIDE 11ß-HALOGENADO ANDRÓGENO Y UN GESTÁGENO ASÍ COMO UN CONTRACEPTIVO MASCULINO SOBRE LA BASE DE ESTAS COMPOSICIONES
PE20060127A1 (es) Sistema de entrega de farmacos constituido por copolimero de polietileno acetato de vinilo
BRPI0116793B8 (pt) produtos de hormônio de esteróide e métodos para prepará-los
AP9801384A0 (en) Improvements of implantation rates after in vitro fertilization.
CY1105276T1 (el) Τριφασικο στοματικο αντισυλληπτικο
DK0868188T3 (da) Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen
ECSP084358A (es) NUEVAS FORMAS SÓLIDAS DE LA MESOPROGESTINA 11ß-[4E-(HIDROXIIMINOMETIL)-FENIL]- 17ALFA-METOXIMETIL-17ß-METOXI-ESTRA-4,9-DIEN-3-ONA
DE122007000011I1 (de) Feste Arzneiformen, enthaltend Clathrate vom steroidalen Sexualhormon Ethinylestradiol
ES2114605T3 (es) Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el.
CR7611A (es) Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona
PE20010579A1 (es) Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos
CO5631449A2 (es) Nuevos esteres de etonogestrel
BR9911344A (pt) Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina.
AU1967300A (en) Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
IT1154735B (it) Derivati d'amino-14 steroidi e procedimento per la loro preparazione
Hahn et al. The pharmacological profile of norgestimate, a new orally active progestin
CU23414B7 (es) Estratrienos 9-alfa-sustituidos como estrógenos de eficacia selectiva
PE20010581A1 (es) Mesoprogestinas (modulares de receptores de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (hrt)
BR0112791A (pt) Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica

Legal Events

Date Code Title Description
FC Refusal